According to BioLineRx's latest financial reports the company's current EPS (TTM) is -ยฃ0.68. In 2022 the company made an earnings per share (EPS) of -ยฃ0.34 an increase over its 2021 EPS that were of -ยฃ0.45.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -ยฃ0.74 | 116.82% |
2022 | -ยฃ0.34 | -25% |
2021 | -ยฃ0.45 | -66.67% |
2020 | -ยฃ1.36 | -29.41% |
2019 | -ยฃ1.93 | -19.05% |
2018 | -ยฃ2.39 | -22.22% |
2017 | -ยฃ3.07 | -3.57% |
2016 | -ยฃ3.18 | -0% |
2015 | -ยฃ3.18 | -17.65% |
2014 | -ยฃ3.86 | -55.26% |
2013 | -ยฃ8.64 | -36.9% |
2012 | -ยฃ13.69 | 11.81% |
2011 | -ยฃ12.24 | -737.01% |
2010 | ยฃ1.92 |